Serum biomarker signature identifies patients with B-cell non-Hodgkin lymphoma associated with cryoglobulinemia vasculitis in chronic HCV infection

Autoimmunity Reviews

Volumn 13, Issue 3, 2014, Pages 319-326

  Terrier, Benjamin ^a,b   Chaara, Wahiba ^a,b,c   Dufat, Laurent ^d   Geri, Guillaume ^a,b   Rosenzwajg, Michelle ^a,b,d   Musset, Lucile ^c   Sène, Damien ^c   Saadoun, David ^a,b,c   Six, Adrien ^a,b   Klatzmann, David ^a,b   Cacoub, Patrice ^a,b,c  

^a Sorbonne Université   (France)

^b CNRS   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

B cell non Hodgkin lymphoma; Biomarkers; Hepatitis C virus; Mixed cryoglobulinemia; Soluble IL 2R

Indexed keywords

CD137 ANTIGEN; CD22 ANTIGEN; CD27 ANTIGEN; COMPLEMENT COMPONENT C4; IMMUNOGLOBULIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN M; INTERLEUKIN 2 RECEPTOR ALPHA; TUMOR MARKER;

ADULT; ASYMPTOMATIC DISEASE; BLOOD LEVEL; CANCER DIAGNOSIS; CONTROLLED STUDY; CRYOGLOBULINEMIA; FEMALE; HEPATITIS C; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTIVE VALUE; REVIEW; SENSITIVITY AND SPECIFICITY; VASCULITIS;

B-CELL NON-HODGKIN LYMPHOMA; BIOMARKERS; HEPATITIS C VIRUS; MIXED CRYOGLOBULINEMIA; SOLUBLE IL-2RΑ;

BIOLOGICAL MARKERS; CRYOGLOBULINEMIA; HEPATITIS C, CHRONIC; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; VASCULITIS;

EID: 84891742318     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2013.11.001     Document Type: Review

References (33)

1. Sansonno L., Tucci F.A., Sansonno S., Lauletta G., Troiani L., Sansonno D. B cells and HCV: an infection model of autoimmunity. Autoimmun Rev 2009, 9:93-94.
2. Agnello V. The aetiology of mixed cryoglobulinaemia associated with hepatitis C virus infection. Scand J Immunol 1995, 42:179-184.
3. Palazzi C., Buskila D., D'Angelo S., D'Amico E., Olivieri I. Autoantibodies in patients with chronic hepatitis C virus infection: pitfalls for the diagnosis of rheumatic diseases. Autoimmun Rev 2012, 11:659-663.
4. Landau D.A., Saadoun D., Calabrese L.H., Cacoub P. The pathophysiology of HCV induced B-cell clonal disorders. Autoimmun Rev 2007, 6:581-587.
5. Vassilopoulos D., Calabrese L.H. Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapies. Arthritis Rheum 2002, 46:585-597.
6. Mazzaro C., Franzin F., Tulissi P., Pussini E., Crovatto M., Carniello G.S., et al. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy. Cancer 1996, 77:2604-2613.
7. Visentini M., Conti V., Cristofoletti C., Lazzeri C., Marrapodi R., Russo G., et al. Clonal expansion and functional exhaustion of monoclonal marginal zone B cells in mixed cryoglobulinemia: the yin and yang of HCV-driven lymphoproliferation and autoimmunity. Autoimmun Rev 2013, 12:430-435.
8. Perotti M., Ghidoli N., Altara R., Diotti R.A., Clementi N., De Marco D., et al. Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia. Autoimmun Rev 2008, 7:468-472.
9. Monti G., Pioltelli P., Saccardo F., Campanini M., Candela M., Cavallero G., et al. Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. Arch Intern Med 2005, 165:101-105.
10. Gisbert J.P., Garcia-Buey L., Pajares J.M., Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology 2003, 125:1723-1732.
11. Ferri C., Cacoub P., Mazzaro C., Roccatello D., Scaini P., Sebastiani M., et al. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. Autoimmun Rev 2011, 11:48-55.
12. Visentini M., Ludovisi S., Petrarca A., Pulvirenti F., Zaramella M., Monti M., et al. A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection. Autoimmun Rev 2011, 10:714-719.
13. Pietrogrande M., De Vita S., Zignego A.L., Pioltelli P., Sansonno D., Sollima S., et al. Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. Autoimmun Rev 2011, 10:444-454.
14. Mazzaro C., Zagonel V., Monfardini S., Tulissi P., Pussini E., Fanni M., et al. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 1996, 94:544-550.
15. Zuckerman E., Zuckerman T., Levine A.M., Douer D., Gutekunst K., Mizokami M., et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997, 127:423-428.
16. Luppi M., Longo G., Ferrari M.G., Barozzi P., Marasca R., Morselli M., et al. Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia. Ann Oncol 1998, 9:495-498.
17. Silvestri F., Barillari G., Fanin R., Zaja F., Infanti L., Patriarca F., et al. Risk of hepatitis C virus infection, Waldenstrom's macroglobulinemia, and monoclonal gammopathies. Blood 1996, 88:1125-1126.
18. Mele A., Pulsoni A., Bianco E., Musto P., Szklo A., Sanpaolo M.G., et al. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood 2003, 102:996-999.
19. Ambrosetti A., Zanotti R., Pattaro C., Lenzi L., Chilosi M., Caramaschi P., et al. Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection. Br J Haematol 2004, 126:43-49.
20. De Vita S., Sacco C., Sansonno D., Gloghini A., Dammacco F., Crovatto M., et al. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood 1997, 90:776-782.
21. Luppi M., Longo G., Ferrari M.G., Ferrara L., Marasca R., Barozzi P., et al. Additional neoplasms and HCV infection in low-grade lymphoma of MALT type. Br J Haematol 1996, 94:373-375.
22. Saadoun D., Suarez F., Lefrere F., Valensi F., Mariette X., Aouba A., et al. Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?. Blood 2005, 105:74-76.
23. Hermine O., Lefrere F., Bronowicki J.P., Mariette X., Jondeau K., Eclache-Saudreau V., et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002, 347:89-94.
24. Vallisa D., Bernuzzi P., Arcaini L., Sacchi S., Callea V., Marasca R., et al. Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience. J Clin Oncol 2005, 23:468-473.
25. Gorevic P.D., Kassab H.J., Levo Y., Kohn R., Meltzer M., Prose P., et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 1980, 69:287-308.
26. Jennette J.C., Falk R.J. Small-vessel vasculitis. N Engl J Med 1997, 337:1512-1523.
27. Harris N.L., Jaffe E.S., Diebold J., Flandrin G., Muller-Hermelink H.K., Vardiman J., et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999, 17:3835-3849.
28. Besson C., Canioni D., Lepage E., Pol S., Morel P., Lederlin P., et al. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs. J Clin Oncol 2006, 24:953-960.
29. Terrier B., Sene D., Saadoun D., Ghillani-Dalbin P., Thibault V., Delluc A., et al. Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders. Ann Rheum Dis 2009, 68:89-93.
30. Geri G., Terrier B., Semoun O., Saadoun D., Sene D., Charlotte F., et al. Surrogate markers of B cell non-Hodgkin's lymphoma in patients with hepatitis C virus-related cryoglobulinaemia vasculitis. Ann Rheum Dis 2010, 69:2177-2180.
31. van Oers M.H., Pals S.T., Evers L.M., van der Schoot C.E., Koopman G., Bonfrer J.M., et al. Expression and release of CD27 in human B-cell malignancies. Blood 1993, 82:3430-3436.
32. Purdue M.P., Lan Q., Bagni R., Hocking W.G., Baris D., Reding D.J., et al. Prediagnostic serum levels of cytokines and other immune markers and risk of non-Hodgkin lymphoma. Cancer Res 2011, 71:4898-4907.
33. Kasama Y., Sekiguchi S., Saito M., Tanaka K., Satoh M., Kuwahara K., et al. Persistent expression of the full genome of hepatitis C virus in B cells induces spontaneous development of B-cell lymphomas in vivo. Blood 2010, 116:4926-4933.